新闻
VNDA
--
0.00%
--
全球管道分析市场前景,行业分析与展望2020
Heraldkeepers · 04/05 11:14
2020年全球失眠疗法市场产品介绍,最新动态,竞争态势和到2025年的动态
Mar 30, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz has published a report titled Global Insomnia Therapy Market Growth (Status and Outlook)...
CDN Newswire · 03/30 21:45
《全球失眠药物市场趋势》报告探讨了2021年至2025年的关键地区,领先国家,公司,消费量,驱动因素,力量分析,收入,机遇和挑战
Mar 25, 2021 (The Expresswire) -- Global "Insomnia Drugs Market" (2021-2025) research provides key analysis on the market status of the Insomnia Drugs...
The Express Wire · 03/25 06:47
失眠药物市场分析,规模,份额,趋势和预测2020-2027 | Ameco Research
pune, India, Wed, 24 Mar 2021 07:37:08 / Comserve Inc. / -- Insomnia Medication Market 2020: This report provides a basic overview of the industry, including...
Comserve · 03/24 14:23
自上升趋势呼吁以来,VNDA的股价上涨了57.5%
marketwatch.com · 03/18 17:45
资本使用回报率概述:Vanda Pharmaceuticals
Looking at Q4, Vanda Pharmaceuticals (NASDAQ:VNDA) earned $10.45 million, a 34.99% increase from the preceding quarter. Vanda Pharmaceuticals also posted a total of $67.65 million in sales, a 12.18% increase since Q3. In Q3, Vanda Pharmaceuticals earned $7...
Benzinga · 03/18 14:11
精神分裂症治疗市场的增长,大小,趋势和参与者(2021-2030)
Mar 11, 2021 (WiredRelease via Comtex) -- The Schizophrenia Treatments Market research study explains and justifies all tools and techniques by a market...
marketresearch.biz · 03/11 08:17
按产品,应用,主要参与者和到2025年的区域分析细分的2020年全球史密斯-马格尼斯综合症市场
Mar 10, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz proclaims the addition of a new report titled Global Smith-Magenis Syndrome Treatment Market...
CDN Newswire · 03/10 19:45
自SmarTrend上升趋势电话(VNDA)以来,Vanda Pharmaceut上涨62.9%
Mar 10, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Vanda Pharmaceut (NASDAQ:VNDA) on October 12th, 2020 at $11.10. In...
marketwatch.com · 03/10 18:02
全球睡眠-觉醒障碍市场趋势,规模,竞争性分析和预测2020-2026
Mar 09, 2021 (Market Insight Reports) -- Clinical developments for sleep disturbances are likely to drive the Sleep-Wake Disorder Market in near future....
Market Insight Reports · 03/09 06:24
2021年全球昼夜节律睡眠障碍市场规模CAGR价值,趋势,驱动因素,增长因素,市场细分,景观和需求到2025年
Mar 05, 2021 (The Expresswire) -- Global “Circadian Rhythm Sleep Disorder Market”is analyzed byproduct types, applications, and key market players formarket...
The Express Wire · 03/05 07:57
时滞疗法市场份额,需求,行业分析,增长,应用,类型和预测报告2027
Mar 04, 2021 (Market Insight Reports) -- The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by...
Market Insight Reports · 03/04 12:11
失眠治疗市场细分和按近期趋势分析,按区域数据消费,发展,调查,到2026年的增长
Mar 03, 2021 (The Expresswire) -- Global “Insomnia Treatment Market” (2021-2026) to its vast repository and growth prospects of the market provides the...
The Express Wire · 03/03 15:56
每日生物技术动向:Adcom测试正在等待强生公司的COVID-19疫苗,礼来公司将向美国提供更多的抗体治疗剂量,特里西达的监管挫折
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 25)
Benzinga · 02/26 13:16
每日生物技术动向:默克去购物,莎瑞达公司的决策日,辉瑞公司,Moderna公布冠状病毒变种的疫苗策略
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 24)
Benzinga · 02/25 13:08
PMI预测,到2030年,全球精神分裂症药物市场将达到98亿美元,复合年增长率为2.7%
Covina CA, Feb 24, 2021 (GLOBE NEWSWIRE via COMTEX) -- Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$...
GlobeNewswire · 02/24 15:05
周五Corbus Pharmaceuticals Holdings Inc.股价上涨,跑赢大盘
marketwatch.com · 02/19 21:38
Corbus Pharmaceuticals Holdings Inc.股票周三下跌,跑输大盘
Shares of Corbus Pharmaceuticals Holdings Inc. slipped 4.92% to $2.90 Wednesday, on what proved to be an all-around mixed trading session for the stock...
marketwatch.com · 02/17 21:39
Corbus Pharmaceuticals Holdings Inc.周二股价上涨,跑赢大盘
Shares of Corbus Pharmaceuticals Holdings Inc. advanced 2.01% to $3.05 Tuesday, on what proved to be an all-around mixed trading session for the stock...
marketwatch.com · 02/16 21:38
自上升趋势呼吁以来,VNDA的股价上涨了64.4%
Feb 16, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Vanda Pharmaceut (NASDAQ:VNDA) on October 12th, 2020 at $11.10. In...
marketwatch.com · 02/16 05:26
微牛提供丰富的实时VNDA股票新闻,让你可以通过多个平台了解VNDA股票行情最新动态,这些免费的万达生物制药新闻可以帮助你做出明智投资。
VNDA 简况
Vanda Pharmaceuticals Inc.是一家生物制药公司。该公司专注于开发和销售用于治疗中枢神经系统(CNS)疾病的药品。该公司的产品组合包括HETLIOZ(他司美琼)、Fanapt(伊潘立酮)、Tradipitant(VLY-686)、曲古柳菌素A和AQW051。该公司提供用于治疗非24小时睡醒周期障碍(非24小时)的HETLIOZ(他司美琼)。该公司提供用于治疗精神分裂症的Fanapt(伊潘立酮)。此外,其分销合作伙伴在以色列和墨西哥推出Fanapt。Tradititant(VLY-686)是一种小分子神经激肽-1受体(NK-1R)拮抗剂,用于临床开发中治疗特应性皮炎的慢性瘙痒。曲古柳菌素A是小分子组蛋白脱乙酰酶(HDAC)抑制剂。AQW051是II期α-7烟碱型乙酰胆碱受体部分激动剂。它专注于治疗CNS疾病。